pharma · postmenopausal women with vasomotor menopausal symptoms
Estetra
Estetra SPRL
Estetra SPRL is a pharma organization headquartered in EU. Primary therapeutic focus areas include postmenopausal women with vasomotor menopausal symptoms. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), a
Company details
- Status
- Public
- HQ
- Liège, BE
- Employees
- 30
- Programs
- 1
- Drugs
- 6
- Patents
- 0
Film-coated placebo to match estetrol monohydrate (E4) 20mg tablet
Phase 2 · small molecule · postmenopausal women with vasomotor menopausal symptoms
Film-coated placebo to match estetrol monohydrate (E4) 20mg tablet for postmenopausal women with vasomotor menopausal symptoms is a Phase 2 program (small_molecule) at Estetra SPRL with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Estetra SPRL
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- postmenopausal women with vasomotor menopausal symptoms
- Status
- active
- Trials
- 1